activating glp-1 receptors Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling: Making the Case for a Functionally Gs Protein-Selective GPCR Glucagon Like Peptide 1 Receptor

US modeling by Blue Cross Blue Shield suggests that broad GLP1 coverage could add measurable pressure to employer premiums over the next decade, depending on uptake and duration of therapy

Hypertension 76:101112

This depends on the dose and vial size: 50mg vial at 1mg/dose = 50 doses 50mg vial at 2mg/dose = 25 doses 100mg vial at 1mg/dose = 100 doses 100mg vial at 2mg/dose = 50 doses 200mg vial at 2mg/dose = 100 doses Community-reported protocols using 1-2mg daily document a 50mg vial lasting 25-50 days

Genes Dev 23:318330 Hennig L, Taranto P, Walser M, Schnrock N, Gruissem W (2003) Arabidopsis MSI1 is required for epigenetic maintenance of reproductive development

Friedreich ataxia- pathogenesis and implications for therapies